CarnoSyn (Beta-Alanine)

CarnoSyn is a patented form of beta-alanine that increases muscle carnosine concentrations by 40-80% after 4-10 weeks of supplementation. It enhances muscular endurance by buffering hydrogen ions that cause fatigue during high-intensity exercise lasting 1-4 minutes.

Origin & History

CarnoSyn is a patented form of beta-alanine, an amino acid that enhances muscle endurance. It is produced through a proprietary process ensuring high purity and efficacy.

Historical & Cultural Context

Beta-alanine supplementation is a relatively recent innovation in sports nutrition, with CarnoSyn leading in research-backed efficacy.

Health Benefits

- Enhances endurance: CarnoSyn is a patented form of beta-alanine, increasing carnosine levels in muscles, enhancing endurance. This allows athletes to train harder and longer. - Reduces muscle fatigue: By buffering lactic acid, CarnoSyn delays the onset of muscle fatigue during high-intensity exercise. This supports prolonged performance. - Supports muscle recovery: CarnoSyn reduces muscle soreness and accelerates recovery post-exercise. This enables more frequent and effective training sessions. - Boosts strength and power: By enhancing muscle carnosine levels, CarnoSyn increases strength and power output. This is crucial for athletes seeking performance gains. - Improves anaerobic capacity: CarnoSyn enhances anaerobic performance, supporting high-intensity activities like sprinting and weightlifting. This is vital for competitive athletes. - Supports cognitive function: Beta-alanine in CarnoSyn supports neurotransmitter function, enhancing focus and mental clarity. This is beneficial for both physical and mental performance. - Promotes overall health: CarnoSyn has antioxidant properties, reducing oxidative stress and supporting overall health. This promotes long-term well-being and vitality.

How It Works

CarnoSyn beta-alanine combines with histidine via carnosine synthase to form carnosine in skeletal muscle fibers. Carnosine acts as an intracellular buffer, neutralizing hydrogen ions produced during anaerobic glycolysis. This buffering action maintains optimal muscle pH and delays the fatigue-inducing effects of acidosis during high-intensity exercise.

Scientific Research

Research, including randomized controlled trials, supports CarnoSyn's role in increasing muscle carnosine levels, improving endurance, and reducing fatigue.

Clinical Summary

Multiple randomized controlled trials involving over 1,500 participants demonstrate CarnoSyn's efficacy at 3.2-6.4g daily doses. Studies show 13-20% improvements in exercise capacity during activities lasting 1-4 minutes, with effects emerging after 2-4 weeks of supplementation. Meta-analyses confirm consistent benefits for high-intensity intermittent exercise, though effects on strength and power output remain limited. The evidence is strongest for trained athletes performing repeated high-intensity bouts.

Nutritional Profile

CarnoSyn is a patented, pure form of beta-alanine (β-alanine), a non-proteinogenic amino acid (C₃H₇NO₂, MW 89.09 g/mol). It contains no significant macronutrients (negligible calories, fat, carbohydrates, or complete protein per typical serving). Key bioactive compound: Beta-alanine at approximately 3,200–6,400 mg per daily serving (standard clinical dosing range). Beta-alanine is the rate-limiting precursor to carnosine (β-alanyl-L-histidine) synthesis in skeletal muscle. Oral bioavailability is high (approximately 90–95% absorption via intestinal transporter PAT1/SLC36A1). Upon ingestion, beta-alanine is taken up by skeletal muscle type II (fast-twitch) fibers via the TauT transporter, where it combines with L-histidine to form carnosine via carnosine synthase. Sustained supplementation (typically 3.2–6.4 g/day over 4–12 weeks) elevates intramuscular carnosine concentrations by approximately 40–80%. Contains no vitamins, minerals, fiber, or fat. No significant micronutrient content. The product is typically free of sugar, gluten, and common allergens. CarnoSyn is distinguished from generic beta-alanine by its patented manufacturing process ensuring >99% purity with verified absence of contaminants (heavy metals, microbial impurities). Peak plasma concentration occurs approximately 30–45 minutes post-ingestion. Paresthesia (tingling sensation) is a common, harmless side effect at single doses exceeding ~800–1,600 mg, which can be mitigated by using sustained-release formulations (SR CarnoSyn) that provide slower, more sustained absorption. Half-life in plasma is approximately 25 minutes, but the functional effect is cumulative through chronic muscle carnosine loading rather than acute dosing.

Preparation & Dosage

Typical dosage is 2 to 5 grams daily. Consult a healthcare provider before use.

Synergy & Pairings

Creatine, Citrulline Malate, Branched-Chain Amino Acids (BCAAs)

Safety & Interactions

CarnoSyn is generally well-tolerated with paresthesia (tingling sensation) being the primary side effect, occurring in 10-20% of users within 15-20 minutes of ingestion. This tingling is harmless and can be minimized by using divided doses or sustained-release formulations. No significant drug interactions have been reported, though it may theoretically interact with GABA-affecting medications due to carnosine's neuromodulatory properties. Safety during pregnancy and breastfeeding has not been established.